Access & Reimbursement Support

Important information and resources to help navigate the reimbursement process

Bristol Myers Squibb is committed to delivering optimal patient and customer experience with cellular therapies. This information will help prescribed patients get access to our CAR T cell therapies and help treatment centers navigate the reimbursement process.

Explore each treatment center milestone throughout the reimbursement process below.

Before Apheresis

1

Access Confirmation

Explore

What's Involved:

Benefit verification, prior authorization, and/or case agreement (if required)


Completion Timing:

Prior to apheresis scheduling

2

Cell Therapy 360® Support Programs Enrollment

Explore

What's Involved:

Enrollment for financial, logistical, and/or coverage verification assistance (online, by fax, or by mail)


Completion Timing:

Patients can enroll at any point during the CAR T cell therapy treatment process; however, for optimal personalized assistance, it is recommended to enroll patients in support programs prior to apheresis scheduling

3

Authorized Distributor Order

Explore

What's Involved:

Product order placed for purchase via authorized distributor’s online portal


Completion Timing:

In a timely manner after apheresis scheduling

After Infusion

4

Claim Submission by Treatment Site

Explore

What's Involved:

Information you may need to complete your claim


Completion Timing:

After product administration

Visit the Resource Library for informative downloadable tools.

For product-specific information: Click here

This information is provided for educational purposes only. Bristol Myers Squibb cannot guarantee insurance coverage or reimbursement. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care and is subject to frequent change. It is the sole responsibility of the healthcare provider to select the proper codes and ensure the accuracy of all statements used in seeking coverage and reimbursement for an individual patient.

CAR=chimeric antigen receptor.